Pfizer: Spondylitis, Ankylosing trials

The registry lists 34 Spondylitis, Ankylosing studies with Pfizer as lead sponsor. 1 are open to participants now and 21 have results posted.

Phase 2 2Phase 3 7Phase 4 9No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Korean Post-marketing Surveillance for Xeljanz XRRecruitingNCT04876781
• Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing SpondylitisCompletedNCT04507763Results posted
• Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)CompletedNCT03502616Phase 3Results posted
• National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeCompletedNCT02925338Results posted
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From RemicadeCompletedNCT02605642Results posted
• Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpACompletedNCT02509026Phase 4Results posted
• Defining Remission With Etanercept in AS in Real Life Clinical PracticeCompletedNCT02202850Results posted
• Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in ItalyCompletedNCT01856569Results posted
• An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical TrialCompletedNCT01793285Results posted
• Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing SpondylitisCompletedNCT01786668Phase 2Results posted
• Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.CompletedNCT01421303Results posted
• A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient DepartmentTerminatedNCT01411215Results posted
• Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural ChangesCompletedNCT01258738Phase 3Results posted
• Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing SpondylitisCompletedNCT01188655Results posted
• Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis PatientsTerminatedNCT00910273Phase 4Results posted
• Study Evaluating Predictors of Response in Patients With Ankylosing SpondylitisCompletedNCT00900796Results posted
• Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in SpainCompletedNCT00873730Phase 4Results posted
• Study Evaluating The Use Of Etanercept In Patients With Ankylosing SpondylitisCompletedNCT00544557Results posted
• Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing SpondylitisCompletedNCT00420238Phase 4Results posted
• Extension Study Evaluating Etanercept in Ankylosing SpondylitisCompletedNCT00410046Phase 4Results posted
• Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic ArthritisTerminatedNCT00273858Results posted
• Study Evaluating Etanercept and Sulphasalazine in Ankylosing SpondylitisCompletedNCT00247962Phase 4Results posted
• A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing SpondylitisCompletedNCT02528201Phase 4
• A Study of ARRY-371797 in Patients With Active Ankylosing SpondylitisTerminatedNCT00811499Phase 2
• Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in AustraliaCompletedNCT00751387
• Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing SpondylitisCompletedNCT00648141Phase 3
• Study Evaluating Etanercept in Patients With Ankylosing SpondylitisCompletedNCT00458185Phase 4
• An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing SpondylitisCompletedNCT00444340Phase 4
• Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing SpondylitisCompletedNCT00434044Phase 3
• An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing SpondylitisCompletedNCT00421980Phase 3
• Study Evaluating Etanercept Treatment of Patients With Ankylosing SpondylitisCompletedNCT00421915Phase 3
• Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing SpondylitisCompletedNCT00418548Phase 3
• Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing SpondylitisCompletedNCT00227227
• Study Investigating Enbrel Treatment for Ankylosing SpondylitisCompletedNCT00195416